Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial
Abstract BackgroundAs the population ages, the prevalence of chronic diseases such as arterial hypertension (AH) and type 2 diabetes (T2D) is increasing, posing challenges for effective management in primary care settings. Although mobile health (mHealth) home telemonitoring o...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-05-01
|
| Series: | JMIR mHealth and uHealth |
| Online Access: | https://mhealth.jmir.org/2025/1/e59733 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850232100757700608 |
|---|---|
| author | Matic Mihevc Majda Mori Lukančič Črt Zavrnik Tina Virtič Potočnik Nina Ružić Gorenjec Marija Petek Šter Zalika Klemenc-Ketiš Antonija Poplas Susič |
| author_facet | Matic Mihevc Majda Mori Lukančič Črt Zavrnik Tina Virtič Potočnik Nina Ružić Gorenjec Marija Petek Šter Zalika Klemenc-Ketiš Antonija Poplas Susič |
| author_sort | Matic Mihevc |
| collection | DOAJ |
| description |
Abstract
BackgroundAs the population ages, the prevalence of chronic diseases such as arterial hypertension (AH) and type 2 diabetes (T2D) is increasing, posing challenges for effective management in primary care settings. Although mobile health (mHealth) home telemonitoring offers promising support, evidence regarding its clinical impact on older patients is limited.
ObjectiveThe objective of this paper was to evaluate the impact of 12-month telemonitoring on clinical outcomes in older individuals with AH and T2D compared to standard care in a primary care setting.
MethodsIn a multicenter, open-label, randomized controlled trial, individuals aged 65 years and older with AH and T2D were randomly assigned in a 1:1 ratio to either a telemonitoring group or a standard care group. The telemonitoring group received mHealth support in addition to standard care. Over 12 months, participants measured blood pressure (BP) twice weekly with 2 consecutive readings each morning and evening, using the second reading as valid. Blood glucose (BG) was measured monthly, both fasting and 90 minutes after meals. Abnormal results triggered a 7-day BP or 1-day BG profile or a teleconsultation with a general practitioner. Meanwhile, the control group received routine care based on integrated care protocols at community health centers. Primary outcomes were the differences between groups in the change in systolic blood pressure (SBP) and HbA1c
ResultsInitially, 128 patients were enrolled, with 117 (91.4%) completing the 12-month follow-up. The mean age was 71.3 (SD 4.7) years, with a mean SBP of 136.7 (SD 14.1) mmHg and mean HbA1cP1cPP1cPP1cP
ConclusionsTelemonitoring effectively improves AH and T2D control in older people but has no impact on other cardiovascular risk factors and diabetes-related quality of life. Future research should explore combining educational and behavioral interventions with telemonitoring to enhance overall health outcomes. However, complex interventions may pose challenges for the elderly, suggesting the need for careful patient selection to ensure that benefits outweigh potential burdens. |
| format | Article |
| id | doaj-art-2570a9ebe90142a188e13ff9c12343ab |
| institution | OA Journals |
| issn | 2291-5222 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR mHealth and uHealth |
| spelling | doaj-art-2570a9ebe90142a188e13ff9c12343ab2025-08-20T02:03:18ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222025-05-0113e59733e5973310.2196/59733Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled TrialMatic Mihevchttp://orcid.org/0000-0003-4041-8682Majda Mori Lukančičhttp://orcid.org/0009-0004-8507-833XČrt Zavrnikhttp://orcid.org/0000-0003-0654-452XTina Virtič Potočnikhttp://orcid.org/0000-0003-4925-3706Nina Ružić Gorenjechttp://orcid.org/0000-0001-8505-1437Marija Petek Šterhttp://orcid.org/0000-0003-1736-2377Zalika Klemenc-Ketišhttp://orcid.org/0000-0002-0270-1754Antonija Poplas Susičhttp://orcid.org/0000-0002-4328-3333 Abstract BackgroundAs the population ages, the prevalence of chronic diseases such as arterial hypertension (AH) and type 2 diabetes (T2D) is increasing, posing challenges for effective management in primary care settings. Although mobile health (mHealth) home telemonitoring offers promising support, evidence regarding its clinical impact on older patients is limited. ObjectiveThe objective of this paper was to evaluate the impact of 12-month telemonitoring on clinical outcomes in older individuals with AH and T2D compared to standard care in a primary care setting. MethodsIn a multicenter, open-label, randomized controlled trial, individuals aged 65 years and older with AH and T2D were randomly assigned in a 1:1 ratio to either a telemonitoring group or a standard care group. The telemonitoring group received mHealth support in addition to standard care. Over 12 months, participants measured blood pressure (BP) twice weekly with 2 consecutive readings each morning and evening, using the second reading as valid. Blood glucose (BG) was measured monthly, both fasting and 90 minutes after meals. Abnormal results triggered a 7-day BP or 1-day BG profile or a teleconsultation with a general practitioner. Meanwhile, the control group received routine care based on integrated care protocols at community health centers. Primary outcomes were the differences between groups in the change in systolic blood pressure (SBP) and HbA1c ResultsInitially, 128 patients were enrolled, with 117 (91.4%) completing the 12-month follow-up. The mean age was 71.3 (SD 4.7) years, with a mean SBP of 136.7 (SD 14.1) mmHg and mean HbA1cP1cPP1cPP1cP ConclusionsTelemonitoring effectively improves AH and T2D control in older people but has no impact on other cardiovascular risk factors and diabetes-related quality of life. Future research should explore combining educational and behavioral interventions with telemonitoring to enhance overall health outcomes. However, complex interventions may pose challenges for the elderly, suggesting the need for careful patient selection to ensure that benefits outweigh potential burdens.https://mhealth.jmir.org/2025/1/e59733 |
| spellingShingle | Matic Mihevc Majda Mori Lukančič Črt Zavrnik Tina Virtič Potočnik Nina Ružić Gorenjec Marija Petek Šter Zalika Klemenc-Ketiš Antonija Poplas Susič Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial JMIR mHealth and uHealth |
| title | Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial |
| title_full | Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial |
| title_fullStr | Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial |
| title_full_unstemmed | Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial |
| title_short | Impact of 12-Month mHealth Home Telemonitoring on Clinical Outcomes in Older Individuals With Hypertension and Type 2 Diabetes: Multicenter Randomized Controlled Trial |
| title_sort | impact of 12 month mhealth home telemonitoring on clinical outcomes in older individuals with hypertension and type 2 diabetes multicenter randomized controlled trial |
| url | https://mhealth.jmir.org/2025/1/e59733 |
| work_keys_str_mv | AT maticmihevc impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT majdamorilukancic impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT crtzavrnik impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT tinavirticpotocnik impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT ninaruzicgorenjec impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT marijapetekster impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT zalikaklemencketis impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial AT antonijapoplassusic impactof12monthmhealthhometelemonitoringonclinicaloutcomesinolderindividualswithhypertensionandtype2diabetesmulticenterrandomizedcontrolledtrial |